Cholesterol-lowering drugs may reduce COVID-19 death in these people

Credit: CC0 Public Domain

In a new study from UC San Diego Health, researchers examined the relationship between the use of medications to control cholesterol or blood pressure levels, and the risk of death among people who were hospitalized due to COVID-19.

They found the use of cholesterol-lowering drugs, known as statins, prior to admission was linked to a 40% reduction in in-hospital death and a 25% reduction in the risk of developing severe symptoms.

In the study, the team used data from more than 10,000 hospitalized COVID-19 patients across the United States/

The analysis compared similar patients who did and did not use statins or high blood pressure medication, among those both with and without underlying health conditions.

The team found that not only are statins and blood pressure medications safe – they may very well be protective in patients hospitalized for COVID, especially among those with a history of hypertension or cardiovascular disease.

They say there is much to be learned about the impacts COVID-19 has on the heart and the cardiovascular system.

This research has the potential to accelerate treatment patterns as we continue to examine best practices and novel pathways that improve patient outcomes.

If you care about COVID and your health, please read studies about this very common drug for heart disease may reduce COVID-19 risk and findings of this new drug 10 times more effective fighting COVID-19.

For more information about COVID, please see recent studies about COVID-19 can spread during dental check and results showing that many people show new symptoms months after COVID-19.

The study is published in PLOS ONE. One author of the study is Lori Daniels, M.D., M.A.S.

Copyright © 2021 Knowridge Science Report. All rights reserved.